03973oam 2200661I 450 991045086530332120200520144314.01-351-21785-21-351-21786-01-351-21784-41-281-09929-597866110992990-7546-8680-910.4324/9781351217866 (CKB)1000000000406712(OCoLC)503443191(CaPaEBR)ebrary10211348(SSID)ssj0000193467(PQKBManifestationID)11167639(PQKBTitleCode)TC0000193467(PQKBWorkID)10226267(PQKB)10483084(MiAaPQ)EBC429715(Au-PeEL)EBL429715(CaPaEBR)ebr10211348(CaONFJC)MIL109929(OCoLC)476277921(OCoLC)1011104087(EXLCZ)99100000000040671220180706d2017 uy 0engurcn|||||||||txtccrLiving Electronic MusicFirst edition.London :Taylor and Francis,2017.1 online resource (214 p.)Bibliographic Level Mode of Issuance: Monograph0-7546-5548-2 0-7546-5546-6 Includes bibliographical references (p. [171]-185) and index.Living presence -- The reanimation of the world : relocating the live -- The human body in electroacoustic music : sublimated or celebrated? -- Playing space : towards an aesthetics of live electronics -- To input the live : microphones and other human activity transducers -- Diffusion-projection : the grain of the loudspeaker."Drawing on recent ideas that explore new environments and the changing situations of composition and performance, Simon Emmerson provides a significant contribution to the study of contemporary music, bridging history, aesthetics and the ideas behind evolving performance practices. Whether created in a studio or performed on stage, how does electronic music reflect what is live and living? What is it to perform 'live' in the age of the laptop? Many performer-composers draw upon a 'library' of materials, some created beforehand in a studio, some coded 'on the fly', others 'plundered' from the widest possible range of sources. But others refuse to abandon traditionally 'created and structured' electroacoustic work. Lying behind this maelstrom of activity is the perennial relationship to 'theory', that is, ideas, principles and practices that somehow lie behind composers' and performers' actions. Some composers claim they just 'respond' to sound and compose 'with their ears', while others use models and analogies of previously 'non-musical' processes. It is evident that in such new musical practices the human body has a new relationship to the sound. There is a historical dimension to this, for since the earliest electroacoustic experiments in 1948 the body has been celebrated or sublimated in a strange 'dance' of forces in which it has never quite gone away but rarely been overtly present. The relationship of the body performing to the spaces around has also undergone a revolution as the source of sound production has shifted to the loudspeaker. Emmerson considers these issues in the framework of our increasingly 'acousmatic' world in which we cannot see the source of the sounds we hear."--Provided by publisher.Electronic musicHistory and criticismMusicPhilosophy and aestheticsElectronic books.Electronic musicHistory and criticism.MusicPhilosophy and aesthetics.786.7Emmerson Simon987000FlBoTFGFlBoTFGBOOK9910450865303321Living Electronic Music2255534UNINA05777nam 2201705z- 450 991055754620332120231214133607.0(CKB)5400000000044145(oapen)https://directory.doabooks.org/handle/20.500.12854/69451(EXLCZ)99540000000004414520202105d2020 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierNovel Biomarkers for Heart DiseaseBasel, SwitzerlandMDPI - Multidisciplinary Digital Publishing Institute20201 electronic resource (420 p.)3-03943-883-2 3-03943-884-0 Cardiac biomarkers such as troponins and natiuretic peptides have made a great impact on clinical decision making as well as improving our understanding of molecular mechanisms of different disease conditions. However, the biomarkers that are currently in use do not reflect all the multiple disease pathways that are involved in a broad spectrum of cardiac disease conditions ranging from acute coronary syndrome, to heart failure (and heart failure with preserved ejection fraction, HFpEF), to pulmonary hypertension or arrhythmias. In this Special Issue, we will provide an overview of the current developments in the field of biomarker research, beginning with research on molecular pathways and cellular communication (e.g., microRNA) up to the clinical use of biomarkers.Medicinebicsscdiet qualityceramidesobesitycardiovascular riskhealthy eating indexcarbohydrate antigen-125heart failureinflammatory markerolder womenbiomarkercardiometabolic diseaseepicardial adipose tissueepicardial fatepicardial fat volumemicroRNAthyroid-stimulating hormonecardiometabolic risksmetabolic syndromehypertensionvery low-density lipoproteinSTIM1SOCEatrial myopathyatrial fibrillationejection fractionsoluble urokinase-type plasminogen activator receptor (suPAR)growth differentiation factor 15 (GDF-15)heart-type fatty acid-binding protein (H-FABP)soluble suppression of tumorigenicity 2 (sST2)acute myocardial infarctionbiomarkerscatestatincoronary artery diseaseheart failure decompensationleft ventricular ejection fractiontroponinNT-proBNPNYHA functional classGDF-15cardiovascular surgeryoperative riskmuscle wastingsarcopeniarenal dysfunctionchronic kidney diseaseaortic diseaseaneurysmmiRNATGF-β pathwayKLF4synthetic phenotypeaortic regurgitationechocardiographymagnetic resonance imagingvena contracta arealongitudinal strainT1 mappingGDF8myostatinAMIceruloplasminH-FABPheart-type fatty acid-binding proteinFABP3fatty acid-binding protein 3HFcardiac biomarkerscardiac magnetic resonance imagingleft ventricular systolic functionmagnetic resonance spectroscopymyocardial triglyceride contentcell adhesion moleculerepeated measurementspregnancy-associated plasma protein-Acohort studiescardiovascular diseasesmitochondrial dysfunctioncirculating cellsPBMCSplateletsoxidative stressreactive oxygen species (ROS)mitochondrial DNA (mtDNA)herat failureliver-type fatty-acid-binding proteinlong-term outcomescardiac intensive care unitsacute kidney injurymyocardial infarctionSTEMIcardiovascular eventscardiovascular deathrisk stratificationsST2Pentraxin-3sudden cardiac deathventricular arrhythmiaventricular tachycardiachronic heart failuresalivasalivary biomarkersCKDCVDPPCIleft ventricular adverse remodellingcirculating miRNAsNAFLDFramingham risk scorerisk predictionsecondary preventionprimary preventionNAFLD fibrosis scoreHFpEFHFrEFsuPARMedicineLichtenauer Michaeledt1287943Lichtenauer MichaelothBOOK9910557546203321Novel Biomarkers for Heart Disease3020593UNINA